Company Data
Lyell Immunopharma Inc.
Ticker
LYEL
Current Price
$9.31 -0.85%
Market Cap
$228.1M
Price Target
Refer to Report
Volume
85.2K
52wk Range
$7.195 - $45
Overview
Lyell Immunopharma Inc is a T cell reprogramming company dedicated towards the mastery of T cells to eradicate solid tumors. Its pipeline includes CARs (Chimeric antigen receptors), TILs (Tumor-infiltrating lymphocytes), and TCRs (T cell receptors).